A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia

Wendy Stock, Samir D. Undevia, Carol Bivins, Farhad Ravandi, Olatoyosi Odenike, Stefan Faderl, Elizabeth Rich, Gautam Borthakur, Lucy Godley, Srdan Verstovsek, Andrew Artz, William Wierda, Richard A. Larson, Yanming Zhang, Jorge Cortes, Mark J. Ratain, Francis J. Giles

Research output: Contribution to journal › Article › peer-review